Innovative Hematology and the Indiana Hemophilia & Thrombosis Center deliver innovative, multi-disciplinary care to pediatric and adult patients. We do this through our wide range of services, collaborative care teams, and clinical research.

Renowned Practitioners

Our nationally and internationally recognized pediatric and adult hematologists provide leadership to the blood disorder community. With a large patient population representing even the rarest disorders, our team’s unique expertise helps us drive advanced research and develop innovative treatment protocols.

Training & Collaboration

Because of our unique approach and patient population, Innovative Hematology trains doctors, nurses, and specialists from other hemophilia treatment centers and hospitals around the country. Our in-depth training helps benefit patients beyond our geographical reach.

Innovative Treatments

Innovative Hematology’s position as a center of excellence for treatment of common and rare blood disorders allows us to pursue innovative treatments. We use our expertise to access the latest therapies and treatment plans, to identify emerging complications, and to enable better outcomes for our patients.

Commitment To Excellence

We routinely seek accreditation by the industry’s top organizations to ensure we’re hitting the mark. Innovative Hematology patients and their loved ones can rest assured our staff go above and beyond to achieve the highest standards in care.

Accreditation Association for Ambulatory Health Care (AAAHC)

Innovative Hematology and the IHTC have achieved national medical home certification by the Accreditation Association for Ambulatory Health Care (AAAHC).

The Indiana Hemophilia and Thrombosis Center (IHTC), Indiana’s only federally recognized Hemophilia Treatment Center, is the first Hemophilia Treatment Center in the U.S. to become a certified medical home by the Accreditation Association for Ambulatory Health Care (AAAHC). This certification recognizes excellence in quality patient-centered health care for organizations that provide medical care on an outpatient basis.

This certification confirms that Innovative Hematology and the IHTC adopt best practices and complies with nationally recognized standards of quality patient-centered health care. The distinction was awarded after an extensive self-assessment and on-site comprehensive review of the organization by the AAAHC surveyors who are actively involved in health care. AAAHC is an independent, not-for-profit organization.

Medical home standards focus on:

• Patient rights and responsibilities, and empowerment
• Organizational governance and administration
• The patient/care team relationship
• Comprehensiveness, continuity and accessibility of care
• Clinical records and health information
• Quality of care

Anticoagulation Center of Excellence (ACE)

The IHTC has been identified as an Anticoagulation Center of Excellence (ACE). The ACE program helps healthcare professionals provide the highest level of care and achieve the best possible outcomes for their patients on antithrombotic medications. Through access to evidence-based guidelines and constantly researched and updated best practices, tools and information, IHTC staff are able to improve outcomes through active participation in patients’ care. The ACE program offers a roadmap to achieving consistent, sustainable excellence in patient care.

HHT-HTC Treatment Center

A Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence (COE) is a medical team recognized by Cure HHT as possessing the personnel, expertise, commitment, and resources to optimally provide comprehensive evaluation, treatment, and education to patients and families with HHT.  The overarching goal of the certification process is to ensure that COE are providing comprehensive, state-of-the-art care to HHT patients and provides a mechanism to ensure that all Centers continue to meet COE standards. It also provides an opportunity for COE to help each other provide HHT care that meets our common, agreed-upon standards.

The criteria to become a HHT-COE was developed in consensus over a period of 2 years by 15 members of the Cure HHT Center Committee. The standard of care provided at COE must be equivalent to or exceed all consensus guidelines approved by the Global Research and Medical Advisory Board of Cure HHT and all local and national standards.

General COE Expectations:

• Educate patients, families, and health care providers about HHT.
• Interact with the non-COE health care providers of HHT patients. 
• Engage in HHT research. 
• Participate in Cure HHT activities.

Accreditation Commission for Health Care (ACHC)

The IHTC pharmacy is accredited as a specialty pharmacy by Accreditation Commission for Health Care (ACHC) for compliance with a comprehensive set of standards. ACHC is a third-party accreditation organization that has developed the highest national standards that providers are measured against in order to illustrate their ability to effectively and efficiently deliver quality healthcare products and services to consumers.

What does it mean for you?

ACHC accreditation requires healthcare organizations to demonstrate compliance with specific quality and process standards. By choosing a healthcare provider that has achieved ACHC accreditation, you can take comfort in knowing that you will receive the highest quality of care.

URAC Accreditation in Specialty Pharmacy

The IHTC pharmacy is proud of its URAC accreditation in Specialty Pharmacy. URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation. By achieving this status, IHTC has demonstrated a comprehensive commitment to quality care, improved processes and better patient outcomes.

The IHTC’s pharmacy program is integrated into the center’s bleeding disorder services. Cost-contained clotting factor concentrate, 24/7 access, rapid statewide delivery, and assay management are a few of the critical benefits available to IHTC pharmacy patients.